Conflict of interest declaration: Ian A Yang

Roles in: Airways Group

1. In the past three years have you accepted the following from an organisation that may gain or lose financially from the publication of reviews by your review group in the Cochrane Database of Systematic Reviews (CDSR)?

a) Reimbursement for attending a conference or symposium (including travel, accommodation and/or hospitality)?
No

b) Fees for speaking?
No

c) Fees for organising education?
No

d) Funds for research?
Yes - My institutions have received project grants and fellowships from the following sources: - National Health and Medical Research (NHMRC) project grants - NHMRC Career Development Fellowship - Queensland Government Health and Medical Research project grants - The Prince Charles Hospital Foundation - Australian Respiratory Council Harry Windsor grant - Faculty of Medicine, The University of Queensland - Australian Cancer Research Foundation

e) Funds for a member of staff?
No

f) Fees for consulting?
No

g) Royalty payments?
No

2. In the past three years have you or your spouse/partner been employed by an organization that may in any way gain or lose financially from the publication of reviews by your review group in the CDSR?
No

3. Do you own stocks or shares in companies that may gain or lose financially from the publication of reviews by your review group in the CDSR?
No

4. Do you hold any patents for products that that may lead you to gain or lose financially from the publication of reviews by your review group in the CDSR?
No

5. Do you have any other competing interests (financial or non-financial)?
Yes - Dr Yang is an employee of Metro North Hospital and Health Service and The University of Queensland. Dr Yang declares that he has not received consultancy fees or honoraria from pharmaceutical companies, and has not acted as a member of advisory boards for pharmaceutical companies. Dr Yang is Chair of the National COPD Guidelines Committee of the Lung Foundation Australia (http://lungfoundation.com.au/). This not-for-profit public benevolent institution which receives grant support from pharmaceutical and other industry companies (Boehringer Ingelheim, Novartis, GSK, AstraZeneca, Air Liquide, Menarini) towards its National COPD Program. He is on the editorial boards of Respirology, Annals of the American Thoracic Society and the Cochrane Airways Group.